文献速递甲状腺与浅表头颈US

超声造影首月随访可预测良性甲状腺结节热消融后再治疗

Contrast enhanced ultrasound at first month: A feasible predictor for retreatment after benign thyroid nodule thermal ablation.
PubMed 文献 · Eur J Radiol · 2026-01-01

本研究纳入155例患者共176个良性甲状腺结节,热消融后首月行常规超声与超声造影,中位随访32.5个月。定量与定性超声造影预测再治疗的AUC分别为0.986和0.981,敏感度均为100%。研究建议良性甲状腺结节热消融后首月常规行超声造影。

要点

  • 热消融后首月超声造影无增强区可提示消融充分,再治疗风险低。
  • 定量与定性超声造影预测再治疗的敏感度及阴性预测值均达100%。
  • 建议良性甲状腺结节热消融后首月随访常规加做超声造影。

核心结论

  • 热消融后首月超声造影是预测良性甲状腺结节再治疗的可行方法。
  • 定量与定性超声造影预测再治疗的AUC分别为0.986和0.981。
  • 定量与定性超声造影的敏感度、阴性预测值均为100%,阴性似然比为0。

研究设计与样本

  • 回顾性研究,共纳入155例患者176个良性甲状腺结节,均接受热消融治疗。
  • 中位随访32.5个月,范围7至83个月。
  • 于热消融后1个月行常规超声及超声造影,计算初始消融比和超声造影初始消融比。

诊断标准与关键数值

  • 定量超声造影预测再治疗的AUC为0.986。
  • 定性超声造影预测再治疗的AUC为0.981。
  • 定量与定性超声造影的敏感度、阴性预测值均为100%,阴性似然比为0。

临床应用与阅片要点

  • 热消融后首月超声造影是预测良性甲状腺结节再治疗的可行手段。
  • 建议对热消融后的良性甲状腺结节在首次随访时常规行超声造影。
  • 超声造影显示消融充分时,再治疗风险很低。

局限性

  • 本研究为单中心回顾性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine the clinical values of contrast enhanced ultrasound (CEUS) at the first follow-up for predicting retreatment in benign thyroid nodules (BTNs) after thermal ablation (TA).

MATERIALS AND METHODS: A total of 176 BTNs from 155 patients who underwent TA with a median follow-up period of 32.5 months (range 7 to 83 months) were enrolled in this study. Initial ablation ratio (IAR) and CEUS base IAR (CIAR) was calculated by conventional US and CEUS at 1-month after TA. The predicting performances for retreatment of quantitative and qualitative CEUS at 1-month after TA were analyzed by receiver operating characteristic (ROC) curves and Kaplan-Meier survival analysis.

RESULTS: The median final volume reduction rate (VRR) of all nodules was 96.9% (range 31.4% to 100%). The areas under curves (AUCs) of quantitative and qualitative CEUS at 1-month for nodular retreatment were 0.986 and 0.981. Correspondingly, the sensitivity, negative predictive value (NPV) and negative likelihood ratio (LR) were 100%, 100% and 0 for both quantitative and qualitative CEUS.

CONCLUSION: CEUS at 1-month is a feasible predictor for nodular retreatment after BTNs TA. According to our results, CEUS is recommended as routine at the first follow-up for BTNs underwent TA.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Yin, Leng, Zheng, et al. Contrast enhanced ultrasound at first month: A feasible predictor for retreatment after benign thyroid nodule thermal ablation. Eur J Radiol. 2026. PMID: 41499912. doi:10.1016/j.ejrad.2025.112628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。